From the *Division of Cardiology, Departments of Medicine and †Radiology, University of Southern California, Los Angeles, CA.
Clin Nucl Med. 2016 Jan;41(1):62-4. doi: 10.1097/RLU.0000000000000990.
Regadenoson is a pharmacologic stress agent that has been widely adopted as an alternative over other pharmacologic vasodilator agents due to its ease of use, patient tolerance, and safety profile. We report the case of dynamic ST-segment elevation electrocardiogram changes after regadenoson injection during an inpatient single-photon emission computed tomography myocardial perfusion stress test, with subsequent coronary angiography revealing the presence of hemodynamically significant coronary artery disease. Our findings confirm that transient regadenoson-induced ST-segment elevations are a marker for hemodynamically significant disease even in the setting of low-risk SPECT perfusion images.
雷卡地诺生是一种药理学应激剂,由于其使用方便、患者耐受性好和安全性良好,已被广泛应用于替代其他药理学血管扩张剂。我们报告了一例在住院单光子发射计算机断层心肌灌注应激试验中注射雷卡地诺生后出现动态 ST 段抬高心电图改变的病例,随后进行冠状动脉造影显示存在血流动力学意义重大的冠状动脉疾病。我们的发现证实,即使在低风险 SPECT 灌注图像的情况下,短暂的雷卡地诺生诱导的 ST 段抬高也是血流动力学意义重大疾病的标志物。